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SA universal definition of conversion rate is lacking and in-
traoperative complications of VATS lobectomy are usually
hidden within these converted cases.
Recently, a study using the Healthcare Cost and Utiliza-
tion Project Nationwide Inpatient Sample database, an in-
surance database, concluded that VATS lobectomy was
associated with a greater number of intraoperative compli-
cations than open lobectomy.10 As with conversion rates,
the definition of intraoperative complications can be ambig-
uous as well. Their definition included accidental puncture
or laceration, foreign body accidentally left during proce-
dure, and bleeding complicating procedure. However,
many believe this database may not capture the desired
end points accurately inasmuch as its primary purpose is
to address health care costs. In addition, the level of thoracic
expertise as reflected by the rate of VATS lobectomy was
lower (6%) than what is available in the STS database
(20%).
Several articles have focused on troubleshooting and
have outlined a predetermined stepwise plan to introduce
VATS lobectomy into their thoracic training programs.11-13
Although these articles try to facilitate the performance of
a successful VATS lobectomy, they do not provide specific
situations to be aware of and none describes measures to
address these situations should they occur.
The incidence of catastrophic intraoperative complica-
tions during VATS lobectomy is low but, when they do oc-
cur, they are manageable. Avoidance is enhanced by solid
knowledge of the anatomic relationships, careful dissection,
awareness of the potential complications described in this
report, and judicious conversion to thoracotomy when ap-
propriate. However, should a catastrophic complication oc-
cur, surgical approach should focus on lung-sparing
techniques as described to limit morbidity. By following
the guidelines presented in this study, surgeons will take
proper caution in performing VATS lobectomies.References
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Dr Daniel L. Miller (Atlanta, Ga). I congratulate you on your
honesty in bringing this to the forefront.
It is interesting that there were 12 patients who were injured in
this study. That is the same number of patients who had major
complications in Dr Park’s robotic series. Were any of these
robotic?
Dr Flores. No.
Dr. Miller. Good answer.
The thing that concerns me is that a lot of this involves anatomic
issues, especially in regard to the pulmonary artery and pulmonary
veins. Total transection of the pulmonary artery and the bronchus
is like a Ralph Lewis procedure. The big thing is, what have you
learned from this and what can you tell the audience? When you
do bronchial stapling, you can do a ventilation test, even though
you had one issue with the middle lobe vein, but what can you
do to prevent this from occurring again to the pulmonary artery
and especially the pulmonary veins? As you know, 15% to 20%
of the time there is a common vein on the left side. What can
you tell us on how to prevent this?
Dr Flores. I have learned many things from reviewing this se-
ries. The first is that it is very difficult to identify these patients
from large databases. Frequently, the query is looking for lobecto-
mies, and that will miss the pneumonectomies that are performed
as a result. I think these complications are actually underreported
in the literature.
With every structure, I have learned a huge deal when it comes
to VATS lobectomy. With the vein, if there is any doubt, take down
the inferior pulmonary ligament. Identify that inferior pulmonary
vein. Identify the superior pulmonary vein. It takes a little more
time, but that is what you need to do. When it comes to the pulmo-
nary artery, I use two rules of thumb. First, make sure the artery is
continuing. When you see a branch, don’t just take it. Make sure
you see more artery going down to the rest of the lung. Avoid
the crotch. A lot of the bleeding comes from going into that crotch,
so go a little bit higher. That will protect you from major bleeding.
As you said, most of us do the bronchus openly, inflating the
lungs before transection. I think another key is, if there is any doubt
about a middle lobe bronchus being hidden in the fissure, maybe
during that situation you want to inflate as well and identify that
you could possibly have included that in the fissure.diovascular Surgery c Volume 142, Number 6 1415
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this particular case, the VATS was performed in the usual way
that most of us would perform it. There was no diaphragmatic in-
jury. What happened was that the fellow continued to push the sta-
pler into the chest, met some resistance at the skin, kept hitting the
diaphragm and hitting the spleen underneath, and that is what led
to an injury. Sowhen you have someone inexperienced on the other
side, make sure that you watch him or her directly and that that sta-
pler is going up and not hitting the diaphragm.
Dr Sugarbaker. Raja, try to be brief. We have a lot of people
who want to discuss your paper.
Dr Miller. The second question is in regard to the lymph node
dissection. Two of the injuries, one to the bronchus and one to the
vena cava, were probably related to the technique of removing
that, because sometimes you can ring forcep, pick up, and cauter-
ize. We have switched to an energy device. We use the EnSeal de-
vice (Ethicon Endo-Surgery, Inc, Cincinnati, Ohio), but a LigaSure
vessel sealing system (ValleyLab, Boulder, Colo), or any bipolar,
can also be used That cuts down on that inadvertent injury to those
associated vessels. Can you comment on that?
Dr Flores.Any kind of new technology warrants practical use. I
know you and Dr Swanson both are enthusiastic about the energy
devices. I do not use them. I use cautery and the argon beam, as
does everyone else on our team. However, I think it is important
to go ahead and look into that. There was an injury with the left
upper lobectomy that I think was as a result of the argon beam,
and then on blunt dissection, the artery opened up. I think we
have to be very careful about vascular injuries, and maybe the en-
ergy will come into play with that.
Dr Miller. The last thing is in regard to quality assurance. It is
very important after these events occur that you have a debriefing
with your team in the operating room. The nurses suffer. They feel
terrible. It is very important to get the team involved in discussing
how to prevent complications in the future. If you do not do that,
there will be future ramifications.
Dr Flores. That is a huge point. We are going to start doing that
at our institution.
Dr G. Alec Patterson (St Louis, Mo). Raja, you should be con-
gratulated. You have a lot of courage and a lot of honesty.
This just reinforces my conviction. This is for everybody in the
room. If you want to get an abstract accepted at the AATS, all you
have to do is put the word ‘‘complication’’ in the title. I was also
going to say that it’s a good thing there were only 12 cases, be-
cause you never would have gotten through it otherwise.
[Laughter.]
Just for clarification, it seems to me that another big problem is
injuries that occur to various structures that result in a thoracotomy
but do not change the ultimate operation. For example, a hole in the
pulmonary artery or in the vein means that you have to make a big
operation out of it, but the patient still just gets a lobectomy. Were
those patients included in this report?
Dr Flores. No.
Dr Patterson. Even patients who had a major amount of blood
loss?
Dr Flores.We tried to focus in on patients who required some
other separate procedure. Now, I included a couple things, like the
superior vena cava injury, just because I thought they were good
learning points. However, in the patient who had a pulmonary1416 The Journal of Thoracic and Cardiovascular Surartery injury where we just took a few Prolene polypropylene su-
tures (Ethicon, Inc, Somerville, NJ) to oversew it, even if the pa-
tient required a unit of blood, we did not include that. That is
actually included in our initial paper from 2009 in which looked
at the complications, and there were 11 of those.
Dr Thomas K. Waddell (Toronto, Ontario, Canada). I am in-
terested just to get into the exploration of why the injuries hap-
pened. I think you did a pretty good job of that, but if I
understood it correctly, it was just from reading the operative
notes. You did not have the opportunity to review videos or to in-
terview the surgeons involved.
Dr Flores. No, I actually did interview the surgeons. We iden-
tified the patients from looking at the operative notes. Once we had
the operative notes, I contacted each individual surgeon and dis-
cussed the case to get specifics.
Dr Waddell. I think it would be very interesting in this kind of
analysis to try to break it down in terms of cognitive versus tech-
nical misadventure. I really applaud you for doing it. It’s very, very
helpful.
Dr Flores. Thank you.
Dr Scott J. Swanson (Boston, Mass). I think you should be a lit-
tle more circumspect, because many injuries that occur during tho-
racotomies are due to lack of understanding of anatomy and
misidentifying anatomy. At least half of your complications
were related to misidentifying anatomy, and so I find it hard to be-
lieve it is not related to experience.When I first began doing VATS,
there were a lot of issues around identifying what we were doing. I
think experience plays a huge role. You are already saying you
know tips to look for veins and look at the arteries. That’s experi-
ence. So I would say (1) this is not just VATS, it’s surgery; (2) I do
believe it is related to experience.
Dr Flores.One of the main points of this paper is that no matter
how experienced you are, it can still happen. You have to be very
vigilant. I do agree with you. I think that with experience, you get
a much decreased rate of your conversions, but even if you’re the
most experienced VATS surgeon, this can still happen.
Dr Tomasz Grodzki (Sczcecin, Poland).Raja, it was a fantastic
paper. I have 2 two short questions.
First, were those complications connected somehow with
a learning curve or did they happen during maturity? Second, I ap-
preciate both teams and the legendary Sloan-Kettering team. The
question is a little bit discreet. Was the distribution of those com-
plications rather equal, or were there some leaders?
Dr Flores. The complications were not by any one specific
surgeon. Each surgeon had at least one or two. And I think it is
important that we learn from these experiences so that it does
not happen when we do it. I’ve learned from just writing this
paper.
Dr Hiran C. Fernando (Boston, Mass). As well as the learning
curve, were there tumor factors that may have helped you predict
these complications happening in advance, or patient factors, such
as adhesions? Have you been able to devise any drills or backup
plans within your team, so that if you have cases like this, you
know how you are going to handle it?
Dr Flores.We looked at that. We tried to figure out if we could
predict anything that could lead us to identify these complications.
Most of the worst complications were on little, tiny things. As you
saw, there was even a pneumonectomy for benign disease. So it isgery c December 2011
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curve, it does not correlate with the surgeon’s experience, and I
think this just stresses the fact that we have to maintain a level
of vigilance when doing these operations. We cannot let our guard
down, ever.
Dr Dominique Grunenwald (Paris, France). Thank you, Raja.
I appreciate your modesty, as usual.
I have a question about patient 4, who had thrombosis of the pul-
monary artery after the operation. Did you give anticoagulation
therapy to this patient during the arterial clamping?
Dr Flores.When it comes to a primary anastomosis, we do not
anticoagulate. In this particular patient, it is interesting that a pneu-
monectomy had to be performed, because the main pulmonary ar-
tery can be tied off and patients can do well with that, as recently
reported in the Journal of Thoracic Surgery in a series of letters to
the editor. So actually we do not use anticoagulation, and we did
not do so in that particular patient.
Dr Grunenwald. This goes along with the question to Dr Ga-
letta yesterday, who did not give anticoagulation therapy during ar-
terial clamping. Personally, I think it is necessary to give such
anticoagulation therapy.
Dr Stephen C. Yang (Baltimore, Md). Again, thanks for con-
fessing your sins.
You said you did not have a complete database for the ability to
check all complications. One of the things I always worry about is
taking out the wrong lobe. You have got a spot and you are not ex-
actly sure. It is sitting in the fissure. You look at the 3-dimensional
reconstruction, and you are still not quite sure. That happened to
me once. I was just curious how often that might happen.
Dr Flores. I appreciate your candor with that. That is something
that frightens me to death, and I have opened patients because I
could not really identify the lobe. The first thing that I explain to
the residents before starting the dissection is that my best instru-
ment is my finger. I put it in there, I make sure I feel where thatThe Journal of Thoracic and Cartumor is, and I will not start the dissection until that happens. If
there’s a doubt, I will open.
Dr Yang.You went through a lot of them in detail. I didn’t quite
understand how you get bilateral fistula from a right middle lobe,
the esophageal fistula.
Dr Flores. That is an interesting case. That patient underwent
a level 7 mediastinal nodal dissection, and I do not know how
that happened. The patient was probably the one who was doing
the worst out of all the complications, and I do not know how to
learn from that. Maybe we need to look at the American College
of Surgeons Oncology Group study of dissection versus sampling.
However, you should not change your operation from thoracotomy
when you are doing it VATS. If you believe in nodal dissection,
complete nodal dissection, then you should do the same with
VATS.
Dr Todd L. Demmy (Buffalo, NY). Have you thought of using
a video bronchoscope that the anesthesiologist can pass to help
identify whether or not an airway is being pinched or narrowed?
That’s useful for the airway complications. For the ones in which
you were unaware of the vessel you were taking in the superior hi-
lum, were you using a high-definition scope or were you able to get
your scope at enough of a right angle so you were really looking at
the lateral hilum so you could see those vessels emerging? Could
that have been an issue for those transection issues?
DrFlores. I think it depends onwhich surgeon you ask. All of us
were using 30 scopes. Initially wewere using regular scopes, then
we transitioned to high-definition scopes, and it did not appear that
that came into play. I think your idea of using a bronchoscope is
helpful in cases in which there is a question. But the thing to
note in this study is that a lot of VATS lobectomies were performed
successfully. A total of 633 VATS lobectomies performed success-
fully is not a small number. That is the reason you have to always
keep your eyes open for one of these potential complications, be-
cause I think a problem will hit you when you least expect it.diovascular Surgery c Volume 142, Number 6 1417
